FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168033812> ?p ?o ?g. }

• W3168033812 endingPage "4580" @default.
• W3168033812 startingPage "4580" @default.
• W3168033812 abstract "4580 Background: Despite advances in the treatment of clear cell RCC, there is a paucity of data to guide management of nccRCC due to the heterogeneity and rarity of these tumors. The clinical activity of new combination therapies (including immunotherapy (IO), anti-vascular endothelial growth factor inhibitors (VEGF), and mammalian target of rapamycin (mTOR) inhibitors) in metastatic nccRCC is not known. Methods: In this multicenter retrospective analysis, we explored the efficacy of combination systemic therapies in patients with nccRCC. Baseline and follow-up demographic, clinical, treatment, and radiographic data were collected. The primary endpoint was objective response rate (ORR) assessed by investigator review. Secondary endpoints include progression- free survival (PFS), disease control rate (DCR), median duration of response (DOR), overall survival (OS), and biomarker correlates. Results: Among 66 included patients, median age was 59 yr; 60% were male and 62% white. Histologies included papillary (38%), chromophobe (17%), unclassified (24%), translocation (12%), and other (9 %). Sarcomatoid and/or rhabdoid differentiation was present in 18%, 70% had prior nephrectomy, 86% were IMDC intermediate/poor risk, 29% and 32% had liver and bone metastasis respectively. 67% received combination treatment in the first line. Comparison of outcomes based on treatment regimen is shown in the table. Conclusions: Antitumor activity was observed with novel combinations in nccRCC which warrants further prospective studies. Response rates and survival with combination therapy in this dataset remain inferior to rates seen in clear cell RCC.[Table: see text]" @default.
• W3168033812 created "2021-06-22" @default.
• W3168033812 creator A5007500935 @default.
• W3168033812 creator A5020125488 @default.
• W3168033812 creator A5022627454 @default.
• W3168033812 creator A5022744341 @default.
• W3168033812 creator A5023152191 @default.
• W3168033812 creator A5023616396 @default.
• W3168033812 creator A5029332651 @default.
• W3168033812 creator A5030296245 @default.
• W3168033812 creator A5031234862 @default.
• W3168033812 creator A5044876102 @default.
• W3168033812 creator A5057146540 @default.
• W3168033812 creator A5058325420 @default.
• W3168033812 creator A5068242137 @default.
• W3168033812 creator A5074019658 @default.
• W3168033812 creator A5079166812 @default.
• W3168033812 creator A5083780107 @default.
• W3168033812 creator A5084523168 @default.
• W3168033812 creator A5086467185 @default.
• W3168033812 creator A5088645680 @default.
• W3168033812 creator A5090727184 @default.
• W3168033812 date "2021-05-20" @default.
• W3168033812 modified "2023-10-14" @default.
• W3168033812 title "Outcomes with novel combinations in non-clear cell renal cell carcinoma(nccRCC): ORACLE study." @default.
• W3168033812 doi "https://doi.org/10.1200/jco.2021.39.15_suppl.4580" @default.
• W3168033812 hasPublicationYear "2021" @default.
• W3168033812 type Work @default.
• W3168033812 sameAs 3168033812 @default.
• W3168033812 citedByCount "1" @default.
• W3168033812 countsByYear W31680338122023 @default.
• W3168033812 crossrefType "journal-article" @default.
• W3168033812 hasAuthorship W3168033812A5007500935 @default.
• W3168033812 hasAuthorship W3168033812A5020125488 @default.
• W3168033812 hasAuthorship W3168033812A5022627454 @default.
• W3168033812 hasAuthorship W3168033812A5022744341 @default.
• W3168033812 hasAuthorship W3168033812A5023152191 @default.
• W3168033812 hasAuthorship W3168033812A5023616396 @default.
• W3168033812 hasAuthorship W3168033812A5029332651 @default.
• W3168033812 hasAuthorship W3168033812A5030296245 @default.
• W3168033812 hasAuthorship W3168033812A5031234862 @default.
• W3168033812 hasAuthorship W3168033812A5044876102 @default.
• W3168033812 hasAuthorship W3168033812A5057146540 @default.
• W3168033812 hasAuthorship W3168033812A5058325420 @default.
• W3168033812 hasAuthorship W3168033812A5068242137 @default.
• W3168033812 hasAuthorship W3168033812A5074019658 @default.
• W3168033812 hasAuthorship W3168033812A5079166812 @default.
• W3168033812 hasAuthorship W3168033812A5083780107 @default.
• W3168033812 hasAuthorship W3168033812A5084523168 @default.
• W3168033812 hasAuthorship W3168033812A5086467185 @default.
• W3168033812 hasAuthorship W3168033812A5088645680 @default.
• W3168033812 hasAuthorship W3168033812A5090727184 @default.
• W3168033812 hasConcept C126322002 @default.
• W3168033812 hasConcept C141071460 @default.
• W3168033812 hasConcept C143998085 @default.
• W3168033812 hasConcept C203092338 @default.
• W3168033812 hasConcept C2777472916 @default.
• W3168033812 hasConcept C2778019345 @default.
• W3168033812 hasConcept C2778560582 @default.
• W3168033812 hasConcept C2778695046 @default.
• W3168033812 hasConcept C2779490328 @default.
• W3168033812 hasConcept C2780739268 @default.
• W3168033812 hasConcept C2781278892 @default.
• W3168033812 hasConcept C2781413609 @default.
• W3168033812 hasConcept C3019894029 @default.
• W3168033812 hasConcept C535046627 @default.
• W3168033812 hasConcept C71924100 @default.
• W3168033812 hasConcept C78795084 @default.
• W3168033812 hasConceptScore W3168033812C126322002 @default.
• W3168033812 hasConceptScore W3168033812C141071460 @default.
• W3168033812 hasConceptScore W3168033812C143998085 @default.
• W3168033812 hasConceptScore W3168033812C203092338 @default.
• W3168033812 hasConceptScore W3168033812C2777472916 @default.
• W3168033812 hasConceptScore W3168033812C2778019345 @default.
• W3168033812 hasConceptScore W3168033812C2778560582 @default.
• W3168033812 hasConceptScore W3168033812C2778695046 @default.
• W3168033812 hasConceptScore W3168033812C2779490328 @default.
• W3168033812 hasConceptScore W3168033812C2780739268 @default.
• W3168033812 hasConceptScore W3168033812C2781278892 @default.
• W3168033812 hasConceptScore W3168033812C2781413609 @default.
• W3168033812 hasConceptScore W3168033812C3019894029 @default.
• W3168033812 hasConceptScore W3168033812C535046627 @default.
• W3168033812 hasConceptScore W3168033812C71924100 @default.
• W3168033812 hasConceptScore W3168033812C78795084 @default.
• W3168033812 hasIssue "15_suppl" @default.
• W3168033812 hasLocation W31680338121 @default.
• W3168033812 hasOpenAccess W3168033812 @default.
• W3168033812 hasPrimaryLocation W31680338121 @default.
• W3168033812 hasRelatedWork W1780497048 @default.
• W3168033812 hasRelatedWork W1995892764 @default.
• W3168033812 hasRelatedWork W2020852956 @default.
• W3168033812 hasRelatedWork W2143079887 @default.
• W3168033812 hasRelatedWork W2233483325 @default.
• W3168033812 hasRelatedWork W2559803332 @default.
• W3168033812 hasRelatedWork W2793006703 @default.
• W3168033812 hasRelatedWork W2895296611 @default.
• W3168033812 hasRelatedWork W2972396084 @default.
• W3168033812 hasRelatedWork W3168033812 @default.

• next